In conclusion, our prospective study has shown that HDL cholesterol efflux normalised to apoA-I was inversely associated with future development of T2DM in a cohort of patients with cardiovascular disease free from T2DM at baseline. Here, APOA1 is linked to cardiovascular disorder.